Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Research Report 2012-2024

July 2019 | 124 pages | ID: GA2B5060811EN
HeyReport

Abstracts

SUMMARY


The global Chemotherapy-Induced Nausea and Vomiting Drugs market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.

Based on products type, the report describes major products type share of regional market. Products mentioned as follows:

• Existing Drugs
• Akynzeo (Netupitant-Palonosetron FDC)
• Aloxi (Palonosetron)
• Emend (Aprepitant)
• Kytril Generic (Granisetron)
• Zofran Generic (Ondansetron)
• Pipeline Drugs
• SUSTOL (Granisetron Injection extended release)
• Rolapitant

Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:

• Merck & Co., Inc.
• GlaxoSmithKline plc
• Tesaro, Inc.
• Helsinn Group
• F. Hoffmann-La Roche Ltd.
• Heron Therapeutics, Inc.
• Dr. Reddy's Laboratories Ltd.
• Acacia Pharma
• Sun Pharmaceutical Industry Ltd.
• Otsuka Holdings Co., Ltd.

Based on Application, the report describes major application share of regional market. Application mentioned as follows:

• Serotonin Receptor Antagonists
• NK1 Receptor Antagonists

Based on region, the report describes major regions market by products and application. Regions mentioned as follows:

• Asia-Pacific
• North America
• Europe
• South America
• Middle East & Africa

Contents

1 MARKET OVERVIEW

1.1 Objectives of Research
  1.1.1 Definition
  1.1.2 Specifications
1.2 Market Segment
  1.2.1 by Type
    1.2.1.1 Existing Drugs
    1.2.1.2 Akynzeo (Netupitant-Palonosetron FDC)
    1.2.1.3 Aloxi (Palonosetron)
    1.2.1.4 Emend (Aprepitant)
    1.2.1.5 Kytril Generic (Granisetron)
    1.2.1.6 Zofran Generic (Ondansetron)
    1.2.1.7 Pipeline Drugs
    1.2.1.8 SUSTOL (Granisetron Injection extended release)
    1.2.1.9 Rolapitant
  1.2.2 by Application
    1.2.2.1 Serotonin Receptor Antagonists
    1.2.2.2 NK1 Receptor Antagonists
  1.2.3 by Regions

2 INDUSTRY CHAIN

2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
  2.3.1 SWOT
  2.3.2 Dynamics

3 ENVIRONMENTAL ANALYSIS

3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry

4 MARKET SEGMENTATION BY TYPE

4.1 Market Size
  4.1.1 Existing Drugs Market, 2013-2018
  4.1.2 Akynzeo (Netupitant-Palonosetron FDC) Market, 2013-2018
  4.1.3 Aloxi (Palonosetron) Market, 2013-2018
  4.1.4 Emend (Aprepitant) Market, 2013-2018
  4.1.5 Kytril Generic (Granisetron) Market, 2013-2018
  4.1.6 Zofran Generic (Ondansetron) Market, 2013-2018
  4.1.7 Pipeline Drugs Market, 2013-2018
  4.1.8 SUSTOL (Granisetron Injection extended release) Market, 2013-2018
  4.1.9 Rolapitant Market, 2013-2018
4.2 Market Forecast
  4.2.1 Existing Drugs Market Forecast, 2019-2024
  4.2.2 Akynzeo (Netupitant-Palonosetron FDC) Market Forecast, 2019-2024
  4.2.3 Aloxi (Palonosetron) Market Forecast, 2019-2024
  4.2.4 Emend (Aprepitant) Market Forecast, 2019-2024
  4.2.5 Kytril Generic (Granisetron) Market Forecast, 2019-2024
  4.2.6 Zofran Generic (Ondansetron) Market Forecast, 2019-2024
  4.2.7 Pipeline Drugs Market Forecast, 2019-2024
  4.2.8 SUSTOL (Granisetron Injection extended release) Market Forecast, 2019-2024
  4.2.9 Rolapitant Market Forecast, 2019-2024

5 MARKET SEGMENTATION BY APPLICATION

5.1 Market Size
  5.1.1 Serotonin Receptor Antagonists Market, 2013-2018
  5.1.2 NK1 Receptor Antagonists Market, 2013-2018
5.2 Market Forecast
  5.2.1 Serotonin Receptor Antagonists Market Forecast, 2019-2024
  5.2.2 NK1 Receptor Antagonists Market Forecast, 2019-2024

6 MARKET SEGMENTATION BY REGION

6.1 Market Size
  6.1.1 Asia-Pacific
    6.1.1.1 Asia-Pacific Market, 2012-2018
    6.1.1.2 Asia-Pacific Market by Type
    6.1.1.3 Asia-Pacific Market by Application
  6.1.2 North America
    6.1.2.1 North America Market, 2012-2018
    6.1.2.2 North America Market by Type
    6.1.2.3 North America Market by Application
  6.1.3 Europe
    6.1.3.1 Europe Market, 2012-2018
    6.1.3.2 Europe Market by Type
    6.1.3.3 Europe Market by Application
  6.1.4 South America
    6.1.4.1 South America Market, 2012-2018
    6.1.4.2 South America Market by Type
    6.1.4.3 South America Market by Application
  6.1.5 Middle East & Africa
    6.1.5.1 Middle East & Africa Market, 2012-2018
    6.1.5.2 Middle East & Africa Market by Type
    6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
  6.2.1 Asia-Pacific Market Forecast, 2019-2024
  6.2.2 North America Market Forecast, 2019-2024
  6.2.3 Europe Market Forecast, 2019-2024
  6.2.4 South America Market Forecast, 2019-2024
  6.2.5 Middle East & Africa Market Forecast, 2019-2024

7 MARKET COMPETITIVE

7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel

8 MAJOR VENDORS

8.1 Merck & Co., Inc.
8.2 GlaxoSmithKline plc
8.3 Tesaro, Inc.
8.4 Helsinn Group
8.5 F. Hoffmann-La Roche Ltd.
8.6 Heron Therapeutics, Inc.
8.7 Dr. Reddy's Laboratories Ltd.
8.8 Acacia Pharma
8.9 Sun Pharmaceutical Industry Ltd.
8.10 Otsuka Holdings Co., Ltd.

9 CONCLUSION

List Of Tables

LIST OF TABLES

Table Product Specifications of Chemotherapy-Induced Nausea and Vomiting Drugs
Table Products Segment of Chemotherapy-Induced Nausea and Vomiting Drugs
Table Existing Drugs Overview
Table Akynzeo (Netupitant-Palonosetron FDC) Overview
Table Aloxi (Palonosetron) Overview
Table Emend (Aprepitant) Overview
Table Kytril Generic (Granisetron) Overview
Table Zofran Generic (Ondansetron) Overview
Table Pipeline Drugs Overview
Table SUSTOL (Granisetron Injection extended release) Overview
Table Rolapitant Overview
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market by Type, 2011-2022 (USD Million)
Table Application Segment of Chemotherapy-Induced Nausea and Vomiting Drugs
Table Serotonin Receptor Antagonists Overview
Table NK1 Receptor Antagonists Overview
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market by Application, 2011-2022 (USD Million)
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market by Region, 2011-2022 (USD Million)
Table Cost of Chemotherapy-Induced Nausea and Vomiting Drugs
Table Market Dynamics
Table Policy of Chemotherapy-Induced Nausea and Vomiting Drugs
Table GDP of Major Countries
Table Existing Drugs CAGR by Revenue and Volume, 2012-2018
Table Akynzeo (Netupitant-Palonosetron FDC) CAGR by Revenue and Volume, 2012-2018
Table Aloxi (Palonosetron) CAGR by Revenue and Volume, 2012-2018
Table Emend (Aprepitant) CAGR by Revenue and Volume, 2012-2018
Table Kytril Generic (Granisetron) CAGR by Revenue and Volume, 2012-2018
Table Zofran Generic (Ondansetron) CAGR by Revenue and Volume, 2012-2018
Table Pipeline Drugs CAGR by Revenue and Volume, 2012-2018
Table SUSTOL (Granisetron Injection extended release) CAGR by Revenue and Volume, 2012-2018
Table Rolapitant CAGR by Revenue and Volume, 2012-2018
Table Existing Drugs CAGR by Revenue and Volume, 2012-2024
Table Akynzeo (Netupitant-Palonosetron FDC) CAGR by Revenue and Volume, 2012-2024
Table Aloxi (Palonosetron) CAGR by Revenue and Volume, 2012-2024
Table Emend (Aprepitant) CAGR by Revenue and Volume, 2012-2024
Table Kytril Generic (Granisetron) CAGR by Revenue and Volume, 2012-2024
Table Zofran Generic (Ondansetron) CAGR by Revenue and Volume, 2012-2024
Table Pipeline Drugs CAGR by Revenue and Volume, 2012-2024
Table SUSTOL (Granisetron Injection extended release) CAGR by Revenue and Volume, 2012-2024
Table Rolapitant CAGR by Revenue and Volume, 2012-2024
Table Serotonin Receptor Antagonists CAGR by Revenue and Volume, 2012-2018
Table NK1 Receptor Antagonists CAGR by Revenue and Volume, 2012-2018
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market by Vendors, 2012-2018 (USD Million)
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market by Vendors, 2012-2018 (in Volume)
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Share by Vendors, 2012-2018 (USD Million)
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Share by Vendors, 2012-2018 (in Volume)
Table Price Factors List
Table Merck & Co., Inc. Profile List
Table Microecological Modulator Operating Data of Merck & Co., Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline plc Profile List
Table Microecological Modulator Operating Data of GlaxoSmithKline plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Tesaro, Inc. Profile List
Table Microecological Modulator Operating Data of Tesaro, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Helsinn Group Profile List
Table Microecological Modulator Operating Data of Helsinn Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table F. Hoffmann-La Roche Ltd. Profile List
Table Microecological Modulator Operating Data of F. Hoffmann-La Roche Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Heron Therapeutics, Inc. Profile List
Table Microecological Modulator Operating Data of Heron Therapeutics, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dr. Reddy's Laboratories Ltd. Profile List
Table Microecological Modulator Operating Data of Dr. Reddy's Laboratories Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Acacia Pharma Profile List
Table Microecological Modulator Operating Data of Acacia Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sun Pharmaceutical Industry Ltd. Profile List
Table Microecological Modulator Operating Data of Sun Pharmaceutical Industry Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Otsuka Holdings Co., Ltd. Profile List
Table Microecological Modulator Operating Data of Otsuka Holdings Co., Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

List Of Figures

LIST OF FIGURES

Figure Chemotherapy-Induced Nausea and Vomiting Drugs Picture
Figure Industry Chain Structure of Chemotherapy-Induced Nausea and Vomiting Drugs
Figure SWOT of Chemotherapy-Induced Nausea and Vomiting Drugs
Figure Existing Drugs Market Size and Growth, 2012-2018 (USD Million)
Figure Existing Drugs Market Size and Growth, 2012-2018 (in Volume)
Figure Akynzeo (Netupitant-Palonosetron FDC) Market Size and Growth, 2012-2018 (USD Million)
Figure Akynzeo (Netupitant-Palonosetron FDC) Market Size and Growth, 2012-2018 (in Volume)
Figure Aloxi (Palonosetron) Market Size and Growth, 2012-2018 (USD Million)
Figure Aloxi (Palonosetron) Market Size and Growth, 2012-2018 (in Volume)
Figure Emend (Aprepitant) Market Size and Growth, 2012-2018 (USD Million)
Figure Emend (Aprepitant) Market Size and Growth, 2012-2018 (in Volume)
Figure Kytril Generic (Granisetron) Market Size and Growth, 2012-2018 (USD Million)
Figure Kytril Generic (Granisetron) Market Size and Growth, 2012-2018 (in Volume)
Figure Zofran Generic (Ondansetron) Market Size and Growth, 2012-2018 (USD Million)
Figure Zofran Generic (Ondansetron) Market Size and Growth, 2012-2018 (in Volume)
Figure Pipeline Drugs Market Size and Growth, 2012-2018 (USD Million)
Figure Pipeline Drugs Market Size and Growth, 2012-2018 (in Volume)
Figure SUSTOL (Granisetron Injection extended release) Market Size and Growth, 2012-2018 (USD Million)
Figure SUSTOL (Granisetron Injection extended release) Market Size and Growth, 2012-2018 (in Volume)
Figure Rolapitant Market Size and Growth, 2012-2018 (USD Million)
Figure Rolapitant Market Size and Growth, 2012-2018 (in Volume)
Figure Existing Drugs Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Existing Drugs Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Akynzeo (Netupitant-Palonosetron FDC) Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Akynzeo (Netupitant-Palonosetron FDC) Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Aloxi (Palonosetron) Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Aloxi (Palonosetron) Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Emend (Aprepitant) Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Emend (Aprepitant) Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Kytril Generic (Granisetron) Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Kytril Generic (Granisetron) Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Zofran Generic (Ondansetron) Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Zofran Generic (Ondansetron) Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Pipeline Drugs Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Pipeline Drugs Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure SUSTOL (Granisetron Injection extended release) Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure SUSTOL (Granisetron Injection extended release) Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Rolapitant Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Rolapitant Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Serotonin Receptor Antagonists Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure NK1 Receptor Antagonists Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (in Volume)
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
Figure North America Market Size and Growth, 2012-2018 (USD Million)
Figure North America Market Size and Growth, 2012-2018 (in Volume)
Figure North America Market Size by Type
Figure North America Market Share by Type
Figure North America Market Size by Application
Figure North America Market Share by Application
Figure Europe Market Size and Growth, 2012-2018 (USD Million)
Figure Europe Market Size and Growth, 2012-2018 (in Volume)
Figure Europe Market Size by Type
Figure Europe Market Share by Type
Figure Europe Market Size by Application
Figure Europe Market Share by Application
Figure South America Market Size and Growth, 2012-2018 (USD Million)
Figure South America Market Size and Growth, 2012-2018 (in Volume)
Figure South America Market Size by Type
Figure South America Market Share by Type
Figure South America Market Size by Application
Figure South America Market Share by Application
Figure Middle East & Africa Market Size and Growth, 2012-2018 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2012-2018 (in Volume)
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
Figure Asia-Pacific Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure North America Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure North America Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Europe Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Europe Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure South America Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure South America Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Middle East & Africa Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Chemotherapy-Induced Nausea and Vomiting Drugs Market Concentration by Region
Figure Marketing Channels Overview